![]() |
|
|
HM Vargas, L Zhou and AJ Gorman
Hoechst-Roussel Pharmaceuticals, Inc., Neuroscience Business Unit, Somerville, New Jersey.
Previous studies suggest that systemic arterial pressure is tonically regulated by the interaction of peripheral sympathetic nerves with vascular alpha-1A adrenoceptors in vivo. To explore this relationship further, the present study examined the inhibitory effect of selective alpha-1A [5-methylurapidil (5-MU) and nifedipine (NIF)] and alpha-1B [chloroethylclonidine (CEC)] antagonists on the pressor response to electrical stimulation (ES) of the spinal cord in pithed rats. Diastolic pressure changes were measured in the presence of 5-MU or CEC and compared with control responses. Pretreatment with 5-MU (0.5 mg/kg i.v.) significantly suppressed the ES pressor response (50-80% inhibition) at all stimulation frequencies. Likewise, NIF (inhibitor of calcium influx associated with alpha-1A adrenoceptor activation) selectively inhibited the pressor response to ES to the same degree as did 5-MU. CEC (25 mg/kg i.v.) also significantly shifted the ES response curve; however, this effect was mediated by activation of presynaptic alpha-2 receptors on sympathetic terminals because prior administration of idazoxan (5 mg/kg) prevented the inhibitory effect of CEC. Based on the potent inhibitory effects of 5-MU and NIF on the ES pressor response in the pithed rat, it was concluded that vascular alpha-1A adrenoceptors reside in the synaptic region of neurovascular junction where they are primarily activated by neuronal norepinephrine release.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
S. A. Townsend, A. S. Jung, Y. S. G. Hoe, R. Y. Lefkowitz, S. A. Khan, C. A. Lemmon, R. W. Harrison, K. Lee, L. A. Barouch, S. Cotecchia, et al. Critical Role for the {alpha}-1B Adrenergic Receptor at the Sympathetic Neuroeffector Junction Hypertension, November 1, 2004; 44(5): 776 - 782. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Guimaraes and D. Moura Vascular Adrenoceptors: An Update Pharmacol. Rev., June 1, 2001; 53(2): 319 - 356. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Guimarães, M. Q. Paiva, and O. Pereira alpha -Adrenoceptor-Mediated Prejunctional Effects of Chloroethylclonidine in the Canine Saphenous Vein J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1326 - 1330. [Abstract] [Full Text] |
||||
![]() |
J. W. Hubbard, S. T. Nordstrom, C. P. Smith, K. M. Brooks, L. Laws-Ricker, L. Zhou, and H. M. Vargas alpha -Adrenergic Activity and Cardiovascular Effects of Besipirdine HCl (HP 749) and Metabolite P7480 in Vitro and in the Conscious Rat and Dog J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 337 - 346. [Abstract] [Full Text] |
||||